论文信息 - Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial - 字舞流文

Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial

T. Doan | E. Suhler | D. C. Miller | H. Al-Dhibi | D. Goldstein | L. Lim | N. Acharya | B. Murugan | J. Gonzales | Radhika Thundikandy | Amit K. Reddy | L. Arellanes-García | Amol A. Sura | S. Rathinam | R. Vedhanayaki | Anuradha V. Kanakath